Add like
Add dislike
Add to saved papers

Predicting Overall Survival of Glioblastoma Patients Using Deep Learning Classification Based on MRIs.

INTRODUCTION: Glioblastoma (GB) is one of the most aggressive tumors of the brain. Despite intensive treatment, the average overall survival (OS) is 15-18 months. Therefore, it is helpful to be able to assess a patient's OS to tailor treatment more specifically to the course of the disease. Automated analysis of routinely generated MRI sequences (FLAIR, T1, T1CE, and T2) using deep learning-based image classification has the potential to enable accurate OS predictions.

METHODS: In this work, a method was developed and evaluated that classifies the OS into three classes - "short", "medium" and "long". For this purpose, the four MRI sequences of a person were corrected using bias-field correction and merged into one image. The pipeline was realized by a bagging model using 5-fold cross-validation and the ResNet50 architecture.

RESULTS: The best model was able to achieve an F1-score of 0.51 and an accuracy of 0.67. In addition, this work enabled a largely clear differentiation of the "short" and "long" classes, which offers high clinical significance as decision support.

CONCLUSION: Automated analysis of MRI scans using deep learning-based image classification has the potential to enable accurate OS prediction in glioblastomas.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app